COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK

Size: px
Start display at page:

Download "COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK"

Transcription

1 COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK Robert L Alesiani, PharmD, CGP Chief Pharmacotherapy Officer CareKinesis, Inc. (a Tabula Rasa Healthcare Company)

2 2

3 3

4 4

5 5

6 Pharmacogenomics (PGx) PGx testing for high-risk individuals (Pharmacogenomic Insight) Pharmacokinetics (PK) Precision Dosing Matrix to detect competitive inhibition within the current drug regimen Pharmacodynamics (PD) Risk/Safety measures to assess aggregate contribution of active medications Pharmacoevidence (PEv) Standard evidenced-based criteria, such as Beers List, STOPP criteria, etc. Pharmacoeconomics (PE) ROI calculation of Medication Risk Mitigation services and cost-benefit analysis regarding pertinent outcomes. 6

7 ANTICHOLINERGICS First Generation Antihistamines: Highly anti-cholinergic, causes greater risk of confusion, dry mouth, constipation and other anticholinergic effects and toxicity. Clearance may be reduced with advanced age; tolerance develops when used as sedative hypnotics. Avoid use except for diphenhydramine in special situations where it may be appropriate (e.g., severe allergic reaction). 2 nd Generation Antihistamines Anti-Parkinson s Drugs: (Benztropine, Trihexyphenidyl) Not recommended for prevention of extrapyramidal symptoms with antipsychotics; more effective agents available for treatment of Parkinson disease. Carbi/Levo, Dopamine Agonists, COMT inhibitors Gastric Antispasmodics: Highly anticholinergic, with poorly documented effectiveness. Avoid except short-term use or utilize lowest effective dose. May be useful in palliative care to decrease oral secretions (disregard risks of long-term ADR s) Tricyclic Antidepressants: Avoid use. Highly anticholinergic, sedating and may cause orthostatic hypotension, syncope and falls. SSRI s (citalopram, escitalopram, sertraline)

8 DIGOXIN (> 0.125MG / DAY) In patients with heart failure and/or low creatinine clearance, higher dosages associated with no additional benefit and increased risk of toxicity. While use of low dose Digoxin may reduce the risk of hospitalization in patients with left ventricular dysfunction, it shows no ( neutral ) benefit for mortality. (Follow CCF/AHA guideline for managing Heart Failure)

9 SPIRONOLACTONE (> 25MG / DAY) In patients with heart failure, risk of hyperkalemia especially if also taking an NSAID, ACE inhibitor, angiotensin receptor blocker, or K supplement; avoid in heart failure or if creatinine clearance < 30 ml/min

10 ANTI-PSYCHOTICS (1 ST & 2 ND GENERATION) Increased risk of stroke and mortality in patients with dementia. Avoid in patients with dementia-related behavior problems unless nonpharmacologic options have failed and patients are a threat to themselves or others. Some antipsychotics may also increase the risks of QT prolongation alone, in susceptible patients with bradycardia and in combination with other drugs that may prolong repolarization (i.e.: Thioridazine, Quetiapine). Antipsychotics should only be used for psychosis. Besides the safety issues listed above, when used for symptom management (agitation, restlessness, yelling out, etc), these agents are only marginally better than placebo. BMJ 2014;349:g6420

11 BENZODIAZEPINES & SIMILAR Short and intermediate-acting: Increased risk of cognitive impairment, delirium, falls, motor vehicle accidents, fractures as well as physical & psychological dependence. Long acting: May be appropriate for seizure disorders, rapid eye movement sleep disorders, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, peri-procedural anesthesia, end-of-life care. Avoid use for insomnia, agitation, or delirium. Non-Benzodiazepine Sedatives: Similar to benzodiazepines (e.g., delirium, falls, fractures); minimal improvement in sleep latency and duration. Not to be used for > 90 days Behavior Modification (Sleep hygiene, relaxation techniques, sleep restriction, light therapy, etc). For pharmacotherapy, use lowest possible dose for shortest amount of time while instituting the techniques above. An agreement with the participant should be established as to the expected duration of therapy (NOTE: Other than alcohol, benzodiazepines are the most abused class of drugs in the elderly).

12 NSAIDS NSAIDs are used by > 30% of people aged 65 to 89, and half of all NSAID prescriptions are for people > 60. Many NSAIDs are available without prescription. The elderly may be prone to adverse effects of these drugs, and adverse effects may be more severe because of the following: NSAIDs are highly lipid-soluble, and because adipose tissue increases with age, distribution of the drugs is extensive. Plasma protein is often decreased, resulting in higher levels of unbound drug and exaggerated pharmacologic effects. Renal function is reduced in many of the elderly, resulting in decreased renal clearance and higher drug levels. Risks of abnormal bleeding increases when NSAIDs are given with warfarin, aspirin, or other antiplatelet drugs (e.g., clopidogrel). NSAIDs may increase risk of cardiovascular events and fluid retention. First Line: Acetaminophen - Prescribing Cascade Alert: PPIs, Diuretics, Antihypertensives, etc.

13 DIURETICS All diuretics should be used with caution and elderly patients should be monitored frequently as the population is pre-disposed to dehydration. Low doses of thiazide diuretics can effectively control hypertension in many elderly patients and have less risk of hypokalemia and hyperglycemia than other diuretics. Potassium sparing diuretics should be used with caution in the elderly as they may often be used in conjunction with ACE-Is, ARBs or with when a participant is prone to impaired kidney function. If required, utilized the lowest effective dose and monitor potassium levels routinely.

14 OTHERS Antibiotics Nitrofurantoin Risk pulmonary toxicity, poor urinary concentration in patients with renal insufficiency Antithrombotics Dipyridamole Risk orthostatic hypotension, other safer, more effective agents available. Cardiovascular α blockers Risk orthostatic hypotension, other safer, more effective agents available. If necessary, use lower effective dose taken at bedtime. α (central) agonists Risk CNS ADRs, bradycardia, orthostatic hypoternsion Nifedipine (IR) Antiarrhythmics classes Ia, Ic & III Risk of hypotension, myocardial ischemia Rate control preferred over rhythm control, avoid as first-line treatment of Atrial Fibrillation (for Amiodarone, increased risk of thyroid and pulmonary disease as well as QT interval prolongation.

15 OTHERS Barbiturates Insulin Sliding Scale Risk of overdose at low dosages. High rate of physical dependence and tolerance. Regardless of care setting, risk hypoglycemia without improvement in glucose control Pain Management Meperidine Risk neurotoxicity, not an effective agent at common oral dosages; safer alternatives available. Skeletal Muscle Relaxants Questionable efficacy at doses that are tolerable to older adults. Highly sedative and anticholinergic. Risk falls and fractures Journal of the American Geriatrics Society 60: , 2012.

16 QUESTIONS?

Geri-PARDY! (2015 Beers Criteria) Pharmacology Edition

Geri-PARDY! (2015 Beers Criteria) Pharmacology Edition Geri-PARDY! Pharmacology Edition (2015 Beers Criteria) Aurelio Muyot, MD, AGSF, FACP Assistant Professor College of Osteopathic Medicine Touro University Nevada Objectives Review the 2015 Beers Criteria

More information

1/21/2016 UPDATE ON THE AMERICAN GERIATRICS SOCIETY 2015 BEERS CRITERIA DISCLOSURE OBJECTIVES AGING GOALS BEERS CRITERIA

1/21/2016 UPDATE ON THE AMERICAN GERIATRICS SOCIETY 2015 BEERS CRITERIA DISCLOSURE OBJECTIVES AGING GOALS BEERS CRITERIA UPDATE ON THE AMERICAN GERIATRICS SOCIETY 2015 BEERS CRITERIA DISCLOSURE I have no financial conflict of interest to disclose. Lacey Charbonneau, Pharm.D. PGY-1 Community Practice Resident Baptist Medical

More information

Fall Prevention in Hospice (A pharmacologic and nonpharmacologic approach)

Fall Prevention in Hospice (A pharmacologic and nonpharmacologic approach) Fall Prevention in Hospice (A pharmacologic and nonpharmacologic approach) Chinenye Emereole, Pharm.D. Clinical Pharmacist Hospice Pharmacy Solutions Objectives Assess and identify hospice patients who

More information

Maximizing Medication Safety UNIVERSITY OF HAWAII AUGUST 31, 2016

Maximizing Medication Safety UNIVERSITY OF HAWAII AUGUST 31, 2016 Maximizing Medication Safety UNIVERSITY OF HAWAII AUGUST 31, 2016 Adverse Drug Events (ADE s) RISK FACTORS FOR Adverse Drug Events (ADEs) 6 or more concurrent chronic conditions 12 or more doses of drugs/day

More information

Chitra Fernando, MD March 18, 2008

Chitra Fernando, MD March 18, 2008 Chitra Fernando, MD March 18, 2008 Definition Statistics Risk factors Why older adults are more prone to ADE Manifestations Inappropriate medications for older adults What can be done to minimize adverse

More information

Condition/Procedure Measure Compliance Criteria Reference Attribution Method

Condition/Procedure Measure Compliance Criteria Reference Attribution Method Premium Specialty: Cardiology Credentialed Specialties include: Cardiac Diagnostic, Cardiology, Cardiovascular Disease, Clinical Cardiac Electrophysiology, and Interventional Cardiology This document is

More information

STOPP and START criteria October 2011

STOPP and START criteria October 2011 # START and STOPP are newer criteria to identify potentially inappropriate medications in elderly, including drug drug and drug disease interactions, drugs which increase risk of falls and drugs which

More information

STOPP START Toolkit Supporting Medication Review in the Older Person

STOPP START Toolkit Supporting Medication Review in the Older Person STOPP START Toolkit Supporting Medication Review in the Older Person STOPP: Screening Tool of Older People s potentially inappropriate Prescriptions START: Screening Tool to Alert doctors to Right (appropriate,

More information

Geriatric Pharmacology

Geriatric Pharmacology Geriatric Pharmacology Janice Scheufler R.Ph.,PharmD, FASCP Clinical Pharmacist Hospice of the Western Reserve Objectives List three risk factors for adverse drug events in the elderly Discuss two physiological

More information

Pharmaceutical form(s)/strength: 50, 100, 200, 400 mg tablets P-RMS:

Pharmaceutical form(s)/strength: 50, 100, 200, 400 mg tablets P-RMS: 0BCore Safety Profile Active substance: Amisulpride Pharmaceutical form(s)/strength: 50, 100, 200, 400 mg tablets P-RMS: IE/H/PSUR/0017/002 Date of FAR: 28.11.2012 Core Safety Profile [amisulpride] Formulations:

More information

Pharmaceutical Care for Geriatrics

Pharmaceutical Care for Geriatrics Continuing Professional Pharmacy Development Program Pharmaceutical Care for Geriatrics Presented by: Alla El-Awaisi; MPharm, MRPharmS, MSc Event Organizer: Dr. Nadir Kheir; PhD Disclaimer: PRESENTING

More information

Geriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center

Geriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center Geriatric Pharmacology Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center Silver Tsunami 2010: 40 million (13%) 2030: 72 million (20%) Baby Boomers (1946-1964)

More information

Summary of Delirium Clinical Practice Guideline Recommendations Post Operative

Summary of Delirium Clinical Practice Guideline Recommendations Post Operative Summary of Delirium Clinical Practice Guideline Recommendations Post Operative Intensive Care Unit Clinical Practice Guideline for Postoperative Clinical Practice Guidelines for the Delirium in Older Adults;

More information

Introductory Clinical Pharmacology Chapter 32 Antiparkinsonism Drugs

Introductory Clinical Pharmacology Chapter 32 Antiparkinsonism Drugs Introductory Clinical Pharmacology Chapter 32 Antiparkinsonism Drugs Dopaminergic Drugs: Actions Symptoms of parkinsonism are caused by depletion of dopamine in CNS Amantadine: makes more of dopamine available

More information

Disclosures. Use caution in the elderly: review of safe and effective medication use in older patients. Institute of Medicine. Learning Objectives

Disclosures. Use caution in the elderly: review of safe and effective medication use in older patients. Institute of Medicine. Learning Objectives Use caution in the elderly: review of safe and effective medication use in older patients Disclosures I have no disclosures or conflicts of interest related to this presentation John T. Holmes, PharmD,

More information

PHARMACOTHERAPY IN THE OLDER PERSON NAMIRAH JAMSHED M.B;B.S ASSOCIATE PROFESSOR UTSW MEDICAL CENTER DALLAS

PHARMACOTHERAPY IN THE OLDER PERSON NAMIRAH JAMSHED M.B;B.S ASSOCIATE PROFESSOR UTSW MEDICAL CENTER DALLAS 1 PHARMACOTHERAPY IN THE OLDER PERSON NAMIRAH JAMSHED M.B;B.S ASSOCIATE PROFESSOR UTSW MEDICAL CENTER DALLAS OBJECTIVES 2 Know and understand: Key issues in geriatric pharmacology Effects of age on pharmacokinetics

More information

OBJECTIVES. Key issues in geriatric pharmacology. Effects of age on pharmacokinetics and pharmacodynamics

OBJECTIVES. Key issues in geriatric pharmacology. Effects of age on pharmacokinetics and pharmacodynamics PHARMACOTHERAPY 1 OBJECTIVES 2 Know and understand: Key issues in geriatric pharmacology Effects of age on pharmacokinetics and pharmacodynamics Risk factors for adverse drug events for older patients

More information

PRESCRIBING IN THE ELDERLY. CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas

PRESCRIBING IN THE ELDERLY. CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas PRESCRIBING IN THE ELDERLY CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas LEARNING OUTCOMES Medicines Optimisation The effects of aging on health and medicines. Polypharmacy Acute Kidney

More information

Medication Assessment and Quality Parameters. Norma J. Owens, PharmD, FCCP Professor of Pharmacy University of Rhode Island

Medication Assessment and Quality Parameters. Norma J. Owens, PharmD, FCCP Professor of Pharmacy University of Rhode Island Medication Assessment and Quality Parameters Norma J. Owens, PharmD, FCCP Professor of Pharmacy University of Rhode Island Financial Disclosure None of the planners, speakers, and/or members of the CME

More information

Pennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10-13, 2016

Pennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10-13, 2016 Pennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10-13, 2016 Disclosures: Drugs in Older Adults: Beers Criteria Heather Sakely,

More information

Medication Use in Older Adults

Medication Use in Older Adults Medication Use in Older Adults F. Michael Gloth, III, MD, AGSF, FACP, CMD Clinical Professor Department of Geriatrics, Florida State University College of Medicine Associate Professor of Medicine Division

More information

There s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients

There s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients There s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients Marilyn N. Bulloch, PharmD, BCPS Assistant Clinical Professor

More information

Prescribing Drugs to the Elderly

Prescribing Drugs to the Elderly Answers to your questions from University of Toronto experts Prescribing Drugs to the Elderly Can drugs do more harm than good? M.A. is a 90-year-old man living at home. He has dementia and due to wandering

More information

20.9 15.4 3.1 0.1 0.2 0.2 0.3 0.4 0.6 0.9 1.5 2.2 9.6 6.1 7.3 4.2 1900 1910 1920 1930 1940 1950 1960 1970 1980 1990 2000 2010 2020 2030 2040 2050 All Ages Age 65+ Age 85+ Female 50.9% Male 49.1% Female

More information

Katee Kindler, PharmD, BCACP

Katee Kindler, PharmD, BCACP Speaker Introduction Katee Kindler, PharmD, BCACP Current Practice: Clinical Pharmacy Specialist Ambulatory Care, St. Vincent Indianapolis Assistant Professor of Pharmacy Practice, Manchester University,

More information

Medications Contributing to Falls. Kate Niemann, PharmD BCGP AuBurn Pharmacy

Medications Contributing to Falls. Kate Niemann, PharmD BCGP AuBurn Pharmacy Medications Contributing to Falls Kate Niemann, PharmD BCGP AuBurn Pharmacy Why Are Falls Important? Leading cause of injury in elders Costs to the system (CDC, 2008) ER Visits: 2.2 million $28.2 billion

More information

START, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy

START, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy START, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy Jessica DiLeo, PharmD Kate Murphy, PharmD OBJECTIVES Identify pharmacodynamic and pharmacokinetic parameters that may influence treatment

More information

Safe and Effective Use of. Psychotropic Drugs. Introduction. Psychotropic Drugs. Jun NAKAMURA

Safe and Effective Use of. Psychotropic Drugs. Introduction. Psychotropic Drugs. Jun NAKAMURA Psychotropic Drugs Safe and Effective Use of Psychotropic Drugs JMAJ 47(6): 259 264, 2004 Jun NAKAMURA Professor, Department of Psychiatry, School of Medicine, University of Occupational and Environmental

More information

Polypharmacy: Guidance for Prescribing in Frail Adults

Polypharmacy: Guidance for Prescribing in Frail Adults Polypharmacy: Guidance for Prescribing in Frail Adults Why is reviewing polypharmacy important? Medication is by far the most common form of medical intervention. Four out of five people aged over 75 years

More information

Prescribing and Pharmacokinetic Considerations in the Elderly

Prescribing and Pharmacokinetic Considerations in the Elderly Prescribing and Pharmacokinetic Considerations in the Elderly Melanie A. Dodd, Pharm.D., Ph.C., BCPS Associate Professor of Pharmacy in Geriatrics College of Pharmacy The University of New Mexico OBJECTIVES

More information

Use caution in the elderly: review of safe and effective medication use in older patients

Use caution in the elderly: review of safe and effective medication use in older patients Use caution in the elderly: review of safe and effective medication use in older patients John T. Holmes, PharmD, BCPS Assistant Professor of Family Medicine and Pharmacy Practice In support of improving

More information

Diabetes and the Elderly: Medication Considerations When Determining Benefits and Risks

Diabetes and the Elderly: Medication Considerations When Determining Benefits and Risks Diabetes and the Elderly: Medication Considerations When Determining Benefits and Risks Gretchen M. Ray, PharmD, PhC, BCACP, CDE Associate Professor UNM College of Pharmacy September 7 th, 2018 DISCLOSURES

More information

DRUGS THAT ACT IN THE CNS

DRUGS THAT ACT IN THE CNS DRUGS THAT ACT IN THE CNS Anxiolytic and Hypnotic Drugs Dr Karamallah S. Mahmood PhD Clinical Pharmacology 1 OTHER ANXIOLYTIC AGENTS/ A. Antidepressants Many antidepressants are effective in the treatment

More information

Using the ASCP-NCOA Falls Risk Reduction Toolkit Part 1: A Companion to CDC's STEADI Toolkit

Using the ASCP-NCOA Falls Risk Reduction Toolkit Part 1: A Companion to CDC's STEADI Toolkit Using the ASCP-NCOA Falls Risk Reduction Toolkit Part 1: A Companion to CDC's STEADI Toolkit Target Audience: Pharmacists ACPE#: 0202-9999-18-056-L01-P Activity Type: Application-based Disclosures Kathleen

More information

BACKGROUND Measuring renal function :

BACKGROUND Measuring renal function : A GUIDE TO USE OF COMMON PALLIATIVE CARE DRUGS IN RENAL IMPAIRMENT These guidelines bring together information and recommendations from the Palliative Care formulary (PCF5 ) BACKGROUND Measuring renal

More information

Antihypertensive drugs SUMMARY Made by: Lama Shatat

Antihypertensive drugs SUMMARY Made by: Lama Shatat Antihypertensive drugs SUMMARY Made by: Lama Shatat Diuretic Thiazide diuretics The loop diuretics Potassium-sparing Diuretics *Hydrochlorothiazide *Chlorthalidone *Furosemide *Torsemide *Bumetanide Aldosterone

More information

Appendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over)

Appendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over) Appendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over) Introduction / Background Treatment comes after diagnosis Diagnosis is based on

More information

Rational prescribing in the older adult. Assoc Prof Craig Whitehead

Rational prescribing in the older adult. Assoc Prof Craig Whitehead Rational prescribing in the older adult Assoc Prof Craig Whitehead Introduction Physioloical ageing and frailty Medication risks in older adults Drug Burden Anticholinergic and sedative drug burden Cascade

More information

Management of DM in Older Adults: It s not all about sugar! Who needs treatment for DM? Peggy Odegard, Pharm.D., BCPS, CDE

Management of DM in Older Adults: It s not all about sugar! Who needs treatment for DM? Peggy Odegard, Pharm.D., BCPS, CDE Management of DM in Older Adults: It s not all about sugar! Peggy Odegard, Pharm.D., BCPS, CDE Who needs treatment for DM? 87 year old, frail male with moderately severe dementia living in NH with persistent

More information

WESTMEAD PRIMARY EXAM GROUP PSYCHOTROPIC MEDICATIONS

WESTMEAD PRIMARY EXAM GROUP PSYCHOTROPIC MEDICATIONS WESTMEAD PRIMARY EXAM GROUP PSYCHOTROPIC MEDICATIONS DOPAMINE HYPOTHESIS Excessive limbic dopamine is hypothesised to cause psychosis Many antipsychotics inhibit dopamine 2 receptors in mesolimbic and

More information

SIFROL â. Contraindications Hypersensitivity to pramipexole or any other component of the product.

SIFROL â. Contraindications Hypersensitivity to pramipexole or any other component of the product. SIFROL â Composition 1 tablet contains 0.088, 0.18 & 0.7 mg (S) 2 amino 4,5,6,7-tetrahydro-6-propylamino-benzothiazole (= pramipexole base) equivalent to 0.125, 0.25 & 1 mg of pramipexole dihydrochloride

More information

SUMMARY OF PRODUCT CHARACTERISTICS FOR BENZODIAZEPINES AS ANXIOLYTICS OR HYPNOTICS

SUMMARY OF PRODUCT CHARACTERISTICS FOR BENZODIAZEPINES AS ANXIOLYTICS OR HYPNOTICS SUMMARY OF PRODUCT CHARACTERISTICS FOR BENZODIAZEPINES AS ANXIOLYTICS OR HYPNOTICS Guideline Title Summary of Product Characteristics for Benzodiazepines as Anxiolytics or Hypnotics Legislative basis Directive

More information

Meds and Falls: Keep in Step with your Meds

Meds and Falls: Keep in Step with your Meds Meds and Falls: Keep in Step with your Meds Donna Bartlett PharmD, CGP, RPh Associate Professor-Pharmacy Practice MCPHS University Clinical Pharmacist-MCPHS University- Pharmacy Outreach Program donna.bartlett@mcphs.edu

More information

POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE

POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE Jeannie Kim Lee, PharmD, BCPS, CGP Clinical Pharmacy Director College of Pharmacy The University of Arizona Learning Objectives: State the risks of

More information

Update in Geriatrics: Choosing Wisely Primum Non Nocere

Update in Geriatrics: Choosing Wisely Primum Non Nocere Joseph G. Ouslander, M.D. Professor of Clinical Biomedical Science Senior Associate Dean for Geriatric Programs Chair, Department of Integrated Medical Science Charles E. Schmidt College of Medicine Professor

More information

Pharmacology. Definitions. Pharmacology Definitions 8/20/2013. Drug:

Pharmacology. Definitions. Pharmacology Definitions 8/20/2013. Drug: Pharmacology Medications and their potential implications in physical therapy Definitions Drug: Any substance that alters physiologic function in the organism, regardless of whether the effect is beneficial

More information

Tranquilizers & Sedative-Hypnotics

Tranquilizers & Sedative-Hypnotics Tranquilizers & Sedative-Hypnotics 1 Tranquilizer or anxiolytic: Drugs used therapeutically to treat agitation or anxiety Sedative-Hypnotic: drugs used to sedate and aid in sleep Original sedatives (before

More information

Delirium. Delirium. Delirium Etiology and Pathophysiology. Fall 2018

Delirium. Delirium. Delirium Etiology and Pathophysiology. Fall 2018 Three most common cognitive problems in adults 1. (acute confusion) 2. Dementia 3. Depression These problems often occur together Can you think of common stimuli for each? 1 1 State of temporary but acute

More information

Antidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych

Antidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych Antidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych A. Heterocyclic antidepressants: (tricyclic and tetracyclic ), e.g.amitryptaline,imipramine. B. Monoamine oxidase inhibitors(m.a.o.i), e.g.phenelzine.

More information

Medicine purposes and side effects

Medicine purposes and side effects Medicine purposes and side effects Ace inhibitors Purpose: Relaxes blood vessels and decreases blood volume, which lowers blood pressure and decreases oxygen demand from the heart Side effects: Low blood

More information

Interface Prescribing Subgroup DRUGS FOR DEMENTIA: INFORMATION FOR PRIMARY CARE

Interface Prescribing Subgroup DRUGS FOR DEMENTIA: INFORMATION FOR PRIMARY CARE Cholinesterase inhibitors and Memantine are now classified as green (following specialist initiation) drugs by the Greater Manchester Medicines Management Group. Who will diagnose and decide who is suitable

More information

Dosing & Administration

Dosing & Administration Dosing & Administration REAL LIFE. REAL RESULTS. INDICATION INVEGA SUSTENNA (paliperidone palmitate) is indicated for the treatment of: Schizophrenia. Schizoaffective disorder as monotherapy and as an

More information

Medication Reviews within Care Homes. Catherine Armstrong

Medication Reviews within Care Homes. Catherine Armstrong Medication Reviews within Care Homes Catherine Armstrong What is a Medication Review? A structured, critical examination of a patient s medicines with the objective of reaching an agreement with the patient

More information

EU RISK MANAGEMENT PLAN (EU-RMP)

EU RISK MANAGEMENT PLAN (EU-RMP) EU RISK MANAGEMENT PLAN (EU-RMP) HYDROXYZINE 25 mg, scored film-coated tablets Active substance(s) (INN or common name): Hydroxyzine hydrochloride Pharmaco-therapeutic group (ATC Code): N05BB01, Anxiolytics

More information

A Primer on Safe Prescribing to the Elderly. Dr. John Puxty

A Primer on Safe Prescribing to the Elderly. Dr. John Puxty A Primer on Safe Prescribing to the Elderly Dr. John Puxty Learning Objectives Describe an approach to safe prescribing for older patients. Appreciate the significance and causes of Polypharmacy. Identify

More information

Medicines save lives

Medicines save lives Optimizing Aging Collaborative Disclosures Too much of a good thing: No financial interests to disclose John Newman, MD, PhD Assistant Professor Division of Geriatrics, UCSF Kirby Lee, PharmD, MAS Associate

More information

CONTRAINDICATIONS TABLE

CONTRAINDICATIONS TABLE CONTRAINDICATIONS TABLE Generic Name Brand Name Contraindications Amphetamine Salts Adderall, Adderall XR Hypersensitivity to amphetamine, dextroamphetamine, or other sympathomimetic amines Advanced arteriosclerosis

More information

A Geriatrician s Perspective on Successful Aging. Ariel Green, MD, MPH Assistant Professor of Medicine

A Geriatrician s Perspective on Successful Aging. Ariel Green, MD, MPH Assistant Professor of Medicine A Geriatrician s Perspective on Successful Aging Ariel Green, MD, MPH Assistant Professor of Medicine 1 Disclosures Johns Hopkins Clinical Research Scholars Program American College of Cardiology Foundation

More information

A Step Forward: Promoting Independence through Falls Prevention

A Step Forward: Promoting Independence through Falls Prevention A Step Forward: Promoting Independence through Falls Prevention 2014 Geriatric Update Meharry Consortium Geriatric Education Center A Step Forward: Promoting Independence through Falls Prevention Moderator:

More information

Antipsychotic Use in the Elderly

Antipsychotic Use in the Elderly Antipsychotic Use in the Elderly Presented by: Fatima M. Ali, PharmD, RPh, BCPS Clinical Consultant Pharmacist MediSystem Pharmacy, Kingston Originally Prepared by: Nicole Tisi BScPhm, RPh ACPR Disclosure

More information

Pharmacology in the Elderly

Pharmacology in the Elderly Pharmacology in the Elderly James Hardy Geriatrician, Royal North Shore Hospital A recent consultation Aspirin Clopidogrel Warfarin Coloxyl with senna Clearlax Methotrexate Paracetamol Pantoprazole Cholecalciferol

More information

Deconstructing Polypharmacy. Alan B. Douglass, M.D. Director

Deconstructing Polypharmacy. Alan B. Douglass, M.D. Director Deconstructing Polypharmacy Alan B. Douglass, M.D. Director Recognize this patient? Mrs. Brown- 82 years young Active Medical Problems Hypertension Hyperlipidemia Type 2 Diabetes Peripheral edema Osteoarthritis

More information

< = > less is more. De-diagnosing De-prescribing Non-testing

< = > less is more. De-diagnosing De-prescribing Non-testing < = > less is more De-diagnosing De-prescribing Non-testing Who says? Overdiagnosis Polypharmacy False positives Too much medicine Risk aversion $$$ Sources Prof David Le Couteur, Clin Pharm and Aged Care

More information

Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist

Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist Medication Dosage Indication for Use Aricept (donepezil) Exelon (rivastigmine) 5mg 23mg* ODT 5mg Solution

More information

Prevention of Medication-Related Falls Through Appropriate Medication Use. Clay Sprouse, MEd., CPhT Piedmont Technical College

Prevention of Medication-Related Falls Through Appropriate Medication Use. Clay Sprouse, MEd., CPhT Piedmont Technical College Prevention of Medication-Related Falls Through Appropriate Medication Use Clay Sprouse, MEd., CPhT Piedmont Technical College Disclosure I have no relevant financial or nonfinancial relationships to disclose

More information

Deprescribing criteria based on NHS PrescQIPP/UKMI document Optimising Safe and Appropriate Medicines Use (OSAMU) [1]

Deprescribing criteria based on NHS PrescQIPP/UKMI document Optimising Safe and Appropriate Medicines Use (OSAMU) [1] Supplementary material for the paper The potential for deprescribing in care home residents with type 2 diabetes, by authors Lillan Mo Andreassen, Reidun Lisbet Skeide Kjome, Una Ørvim Sølvik, Julie Houghton,

More information

Pitfalls in Pharmacotherapy of Geriatrics

Pitfalls in Pharmacotherapy of Geriatrics Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD) Case Study An 85 year old female with a history of atrial fibrillation, stroke, dementia, and hypertension, who is receiving chronic

More information

High Risk Medications: What Can Community Pharmacists Do to Make Patients Safer?

High Risk Medications: What Can Community Pharmacists Do to Make Patients Safer? CONTINUING EDUCATION High Risk Medications: What Can Community Pharmacists Do to Make Patients Safer? by Sean T. Lasota, PharmD Sept. 1, 2015 (expires Sept. 1, 2018) Activity Type: Knowledge-based To earn

More information

Management of Behavioral Problems in Dementia

Management of Behavioral Problems in Dementia Management of Behavioral Problems in Dementia Ghulam M. Surti, MD Clinical Assistant Professor Department of Psychiatry and Human Behavior Warren Alpert Medical School of Brown University Definition of

More information

Definition and Statistics

Definition and Statistics Objectives 1. Describe the basic principles of how drugs work in the body and with one another. Nanette R Wrobel, RPh Director of Education/Clinical Director Pharmacy Alternatives 2. Identify the four

More information

Management of Delirium in Hospice Patients

Management of Delirium in Hospice Patients Presentation Objectives Management of Delirium in Hospice Patients Lynn Williams, BSPharm Clinical Pharmacist Hospice Pharmacy Solutions Identify the clinical features of delirium Understand the underlying

More information

University of Hawaii Center on Aging

University of Hawaii Center on Aging University of Hawaii Center on Aging. Supported in part by a cooperative agreement No. 90AL0011-01-00 from the Administration on Aging, Administration for Community Living, U.S. Department of Health and

More information

De-prescribing in Older Adults. Wael Hamade, MD, FAAFP 04/08/2016

De-prescribing in Older Adults. Wael Hamade, MD, FAAFP 04/08/2016 De-prescribing in Older Adults Wael Hamade, MD, FAAFP 04/08/2016 DISCLOSURES None of the faculty, planners, speakers, providers nor CME committee has any relevant financial relationships with commercial

More information

SIFROL Composition Properties Indication

SIFROL Composition Properties Indication SIFROL Boehringer Composition 1 tablet contains: 0.125, 0.25 or 1.0 mg, (S)-2- amino-4,5,6,7-tetrahydro-6-propylamino-benzothiazole dihydrochloride monohydrate equivalent to 0.088, 0.18 or 0.7 mg pramipexole

More information

Western University of Health Sciences, College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of

Western University of Health Sciences, College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of Western University of Health Sciences, College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Topic UAN# Target Audience A

More information

Updates to CMS SOM rules on Psychosocial Issues, Deficiency Categorization, and Psychotropic Medication Use

Updates to CMS SOM rules on Psychosocial Issues, Deficiency Categorization, and Psychotropic Medication Use Updates to CMS SOM rules on Psychosocial Issues, Deficiency Categorization, and Psychotropic Medication Use Stephen Eide R. Ph Oni Kinberg LCSW, MSSW Updates to the SOM On March 25, 2016 CMS sent out updates

More information

Cognitive enhancers PINCH ME. Anticholinergic burden BPSD. Agitation, Aggression and antipsychotics

Cognitive enhancers PINCH ME. Anticholinergic burden BPSD. Agitation, Aggression and antipsychotics Cognitive enhancers PINCH ME Anticholinergic burden BPSD Agitation, Aggression and antipsychotics 2 types Cholinesterase inhibitors licensed for mild to moderate AD Donepezil Galantamine Rivastigmine also

More information

M0BCore Safety Profile. Active substance: Bromazepam Pharmaceutical form(s)/strength: Tablets 6 mg FR/H/PSUR/0066/001 Date of FAR:

M0BCore Safety Profile. Active substance: Bromazepam Pharmaceutical form(s)/strength: Tablets 6 mg FR/H/PSUR/0066/001 Date of FAR: M0BCore Safety Profile Active substance: Bromazepam Pharmaceutical form(s)/strength: Tablets 6 mg P-RMS: FR/H/PSUR/0066/001 Date of FAR: 26.11.2013 4.3 Contraindications Bromazepam must not be administered

More information

Pharmaceutical Interventions. Collaborative Model of Mental Health Care for Older Iowans Des Moines May 18, 2007

Pharmaceutical Interventions. Collaborative Model of Mental Health Care for Older Iowans Des Moines May 18, 2007 Pharmaceutical Interventions Collaborative Model of Mental Health Care for Older Iowans Des Moines May 18, 2007 Outline Overview Overview of initial workup and decisions in elderly depressed individual

More information

Section 3, Lecture 2

Section 3, Lecture 2 59-291 Section 3, Lecture 2 Diuretics: -increase in Na + excretion (naturesis) Thiazide and Related diuretics -decreased PVR due to decreases muscle contraction -an economical and effective treatment -protect

More information

Appendix 3: Screening Tool of Older Persons Prescriptions (STOPP) version 2.

Appendix 3: Screening Tool of Older Persons Prescriptions (STOPP) version 2. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2 By Denis O'Mahony, David O'Sullivan, Stephen Byrne, Marie Noelle O'Connor, Cristin Ryan and Paul Gallagher Age

More information

Polypharmacy: What the Nurse Practitioner Should Know Audrey M. Stevenson PhD, MPH, MSN, FNP-BC Las Vegas 2017

Polypharmacy: What the Nurse Practitioner Should Know Audrey M. Stevenson PhD, MPH, MSN, FNP-BC Las Vegas 2017 Polypharmacy: What the Nurse Practitioner Should Know Audrey M. Stevenson PhD, MPH, MSN, FNP-BC Las Vegas 2017 Disclosure I have no current affiliation or financial arrangement with any grantor or commercial

More information

2/1/2013. Poisoning pitfalls. The original pitfall

2/1/2013. Poisoning pitfalls. The original pitfall The original pitfall Poisoning pitfalls Craig Smollin MD Associate Medical Director, California Poison Control System - SF Division Assistant Professor of Emergency Medicine, UCSF What will we talk about?

More information

National Medicines Information Centre ST. JAMES S HOSPITAL DUBLIN 8 TEL or FAX

National Medicines Information Centre ST. JAMES S HOSPITAL DUBLIN 8 TEL or FAX National Medicines Information Centre ST. JAMES S HOSPITAL DUBLIN 8 TEL 01-4730589 or 1850-727-727 FAX 01-4730596 www.nmic.ie PRESCRIBING IN THE ELDERLY INTRODUCTION According to the most recent census

More information

Polypharmacy: What the Nurse Practitioner Should Know Audrey M. Stevenson PhD, MPH, MSN, FNP-BC Nashville, TN 2017

Polypharmacy: What the Nurse Practitioner Should Know Audrey M. Stevenson PhD, MPH, MSN, FNP-BC Nashville, TN 2017 What is Polypharmacy Polypharmacy: What the Nurse Practitioner Should Know Audrey M. Stevenson PhD, MPH, MSN, FNP-BC Nashville, TN 2017 The use of multiple medications simultaneously Rx OTC Herbal Disclosure

More information

Falls most commonly seen in RACFs are due to tripping, slipping and stumbling (21.6%). Falling down stairs is relatively uncommon in

Falls most commonly seen in RACFs are due to tripping, slipping and stumbling (21.6%). Falling down stairs is relatively uncommon in This Presentation Medications and Falls Dr Peter Tenni M Pharm (Curtin), PhD (UTAS) AACPA Director, CPS A fall is an event which results in a person coming to rest inadvertently on the ground or floor

More information

Chapter 10 Worksheet Blood Pressure and Antithrombotic Agents

Chapter 10 Worksheet Blood Pressure and Antithrombotic Agents Complete the following. 1. A layer of cells lines each vessel in the vascular system. This layer is a passive barrier that keeps cells and proteins from going into tissues; it also contains substances

More information

Guidelines MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD)

Guidelines MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD) MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD) Guidelines CH Lim, B Baizury, on behalf of Development Group Clinical Practice Guidelines Management of Major Depressive Disorder A. Introduction Major depressive

More information

Disclosures. Outline. Epidemiology. Medication Management in the Elderly. In 2008 pts age 65 and older represented 40% of all hospitalized adults

Disclosures. Outline. Epidemiology. Medication Management in the Elderly. In 2008 pts age 65 and older represented 40% of all hospitalized adults Medication Management in the Elderly Disclosures Melissa Stevens MD Atlanta VA Medical Center Assistant Professor Emory University Department of Medicine I have no significant financial interest or other

More information

PRESCRIBING PRACTICE IN DELIRIUM. John Warburton Critical Care Pharmacist

PRESCRIBING PRACTICE IN DELIRIUM. John Warburton Critical Care Pharmacist PRESCRIBING PRACTICE IN DELIRIUM John Warburton Critical Care Pharmacist Learning outcomes Modifiable medication risk factors for delirium An appreciation of contributing factors modifiable with medicines

More information

BEERs For the Elderly

BEERs For the Elderly BEERs For the Elderly February 2008 Presented by:carla Ambrosini Seniors First Clinic Pharmacist 12/05/2008 1 Objectives To highlight the overall health care impact of drug related adverse reactions and

More information

Potentially Inappropriate Medication Use in Older Adults 2015 Latest Research

Potentially Inappropriate Medication Use in Older Adults 2015 Latest Research Home Resources Potentially Inappropriate Medication Use in Older Adults 2015 Resources Potentially Inappropriate Medication Use in Older Adults 2015 Latest Research Drugs and Categories of Drugs What these

More information

Prior Authorization with Quantity Limit Program Summary

Prior Authorization with Quantity Limit Program Summary Gocovri (amantadine) Prior Authorization with Quantity Limit Program Summary This prior authorization applies to Commercial, NetResults A series, SourceRx and Health Insurance Marketplace formularies.

More information

SECTION 9 : MANAGEMENT OF MOVEMENT DISORDERS AND EXTRAPYRAMIDAL SIDE EFFECTS

SECTION 9 : MANAGEMENT OF MOVEMENT DISORDERS AND EXTRAPYRAMIDAL SIDE EFFECTS SECTION 9 : MANAGEMENT OF MOVEMENT DISORDERS AND EXTRAPYRAMIDAL SIDE EFFECTS Formulary and Prescribing Guidelines 9.1 Introduction Movement disorders and extrapyramidal side effects can manifest in the

More information

7/7/ CHD/MI LVH and LV dysfunction Dysrrhythmias Stroke PVD Renal insufficiency and failure Retinopathy. Normal <120 Prehypertension

7/7/ CHD/MI LVH and LV dysfunction Dysrrhythmias Stroke PVD Renal insufficiency and failure Retinopathy. Normal <120 Prehypertension Prevalence of Hypertension Hypertension: Diagnosis and Management T. Villela, M.D. Program Director University of California, San Francisco-San Francisco General Hospital Family and Community Medicine

More information

CIZOREST Tablets (Amisulpride)

CIZOREST Tablets (Amisulpride) Published on: 2 Dec 2015 CIZOREST Tablets (Amisulpride) Composition CIZOREST 50mg Tablets Each film-coated tablet contains: Amisulpride..50 mg CIZOREST 100mg Tablets Each film-coated tablet contains: Amisulpride..100

More information

Nuplazid. (pimavanserin) New Product Slideshow

Nuplazid. (pimavanserin) New Product Slideshow Nuplazid (pimavanserin) New Product Slideshow Introduction Brand name: Nuplazid Generic name: Pimavanserin Pharmacological class: Atypical antipsychotic Strength and Formulation: 17mg; tablets Manufacturer:

More information

LACIPIL QUALITATIVE AND QUANTITATIVE COMPOSITION

LACIPIL QUALITATIVE AND QUANTITATIVE COMPOSITION LACIPIL lacidipine QUALITATIVE AND QUANTITATIVE COMPOSITION Lacidipine, 2 mg - round shaped white engraved on one face. Lacidipine, 4 mg - oval white with break line on both faces. Lacidipine, 6 mg - oval

More information

Polypharmacy. Polypharmacy. Suboptimal Prescribing in Older Adults. Kenneth Schmader, MD Professor of Medicine-Geriatrics

Polypharmacy. Polypharmacy. Suboptimal Prescribing in Older Adults. Kenneth Schmader, MD Professor of Medicine-Geriatrics Polypharmacy Kenneth Schmader, MD Professor of Medicine-Geriatrics Polypharmacy Definition Causes Consequences Prevention/management Suboptimal Prescribing in Older Adults Overuse Polypharmacy Underuse

More information